The verified answer
As of Sep 2026, DEPLOY verifies Precision Neuroscience: 1 model, 2 deployments across 2 regions, $120.0M raised. 2 sources back the record.
CategoryBiometric wearables
Overview
Precision Neuroscience is a New York-based brain-computer interface company developing the Layer 7 Cortical Interface, a minimally invasive, safely removable BCI with 1,024 electrodes on a thin flexible film. FDA 510(k) clearance granted April 2025 — first full regulatory clearance for a next-generation wireless BCI.
Tested in 37 patients across Mount Sinai, Penn Medicine, WVU Rockefeller Neuroscience Institute, and Beth Israel. Raised $161M total (Series B $41M, Series C $120M).
Verified record
- Verified deployments
- 2 deployments on file
- Active incidents
- None on file
Valuation of record
DEPLOY VERIFIEDPriced roundSeries C post-money
Key facts
Headquarters
Founded
Status
Type
Data & sources
Press releases
1
Web sources
1
2 sources backing this record.View all →
Models (1)
View all models →Precision Neuroscience on the deployment map
View the global map2 verified deployments across 2 regions, newest verified Jun 2024. Explore where Precision Neuroscience's robots are operating, by place and type.
View the full Precision Neuroscience deployment record →
Relationships
Current leadership (2)
- Michael Mager CEO & Co-Foundersecondary-verified
- Dr. Benjamin Rapoport Co-Founder & Chief Science Officersecondary-verified
Founders (1)
- Dr. Benjamin Rapoportcofounder
later founded Neuralink
Safety record
No incidents on record for Precision Neuroscience.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Operator customers (1)
- Precision Neuroscience2 deployments
Recent coverage
Precision Neuroscience in third-party press
Peers
3 peers across 1 segment. Every Precision Neuroscience competitor derived from shared form-factor and application-domain edges.
bci(3)
3 companies in this segment · highly_concentrated (HHI 3365.5523463639224) · leader Blackrock Neurotech at 3565%
- Blackrock Neurotechdirect competitor(inferred)strong
- Paradromicsdirect competitor(inferred)strong
- Synchrondirect competitor(inferred)strong
Financial state
- Total funding
- $120.0M
- Reporting basis
- aggregator_estimate
- Lifecycle stage
- mature
- Counterparty risk class
- unknown
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Funding rounds (1)
- Series C2024-11-01
$120M(reported) · $1.2B post
Investors: B Capital
Timeline
Every recorded move in Precision Neuroscience’s history, most recent first: funding rounds, partnerships, acquisitions, supply-chain starts, key hires, and press.
Funding roundSeries C funding round
2024-11-01Series C raising $120000000
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdAug 8, 2026
Added to the verified registry
- Deployment verifiedVerifiedJun 1, 2024
Precision Layer 7 Cortical Interface at United States (multiple hotel chains)
- Deployment verifiedVerifiedJun 1, 2024
Precision Layer 7 Cortical Interface at Germany, Europe
Sources (2)
Common questions
What is Precision Neuroscience?
What does Precision Neuroscience make?
Is Precision Neuroscience publicly traded?
Who competes with Precision Neuroscience?
Who is the CEO of Precision Neuroscience?
How can I invest in Precision Neuroscience?
Where is Precision Neuroscience headquartered?
How much funding has Precision Neuroscience raised?
Who owns Precision Neuroscience?
Where does Precision Neuroscience operate robots?
How many robots has Precision Neuroscience deployed?
Is Precision Neuroscience a top robotics company?
When was Precision Neuroscience founded?
Is Precision Neuroscience safe?
Methodology: Verified · 2 sources (1 primary) · last reviewed 2026-08-21
Verification posture
Verified
High confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 1
- primary-company-ir
- Company IR disclosure
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Precision Neuroscience.Peer companies
- Google21 models
- Samsung Electronics4 models
- Butterfly Network2 models
- Abbott1 model
- Apple1 model
- Blackrock Neurotech1 model
In the press
Recent coverage mentioning Precision Neuroscience from third-party publications. Automatically surfaced; not part of the verified registry record.
Machine-readable surfaces
- Markdown mirror: /companies/precision-neuroscience.md
- RSS feed: /companies/precision-neuroscience/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/3ff7a5a1-3c3e-48a7-8a07-1e3dcd200da8
- Revision history: /companies/precision-neuroscience/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Google21 models
- Samsung Electronics4 models
- Butterfly Network2 models
- Abbott1 model
- Apple1 model
- Blackrock Neurotech1 model
Video
Imagine being able to control a computer cursor with your mind. While it may sound like science fiction to many, major companies like Meta (META) and Apple (AAP
#ALS #ExpertTalk on Implantable BCI Technology, with: - Craig Mermel, President and Chief Product Officer - Precision Neuroscience - Spencer Kellis, Sr. Team L
"Precision neuroscience: A journey through McGovern research" Robert Desimone, Director, McGovern Institute, MIT Learn more about Prof. Desimone's work: https:
Scientists are building on existing technologies and innovating new ones to develop prosthetics such as "soft" robots, brain-machine interfaces, and an organic
The international Precision Neuroscience Conference builds on a collaboration between Nordic and Virginia universities to advance neuroscience-based precision m
The President and CPO of Precision Neuroscience discusses how #braincomputerinterface technology is a clinical breakthrough and can help address a huge healthca
Join us on the latest episode! Our Guest: Craig Mermel, President & CPO at Precision Neuroscience What you'll get out of this episode: - Craig Mermel discusses
Interview with Laurence Barker, Partner, Dementia Discovery Fund #science #shorts #neuroscience #venturecapital #unitedkingdom
At Precision Neuroscience, we’re building the next generation of brain-computer interfaces — designed to restore independence and transform care for people livi
A deep dive into the latest micro robot swarm breakthrough and its potential to transform medical care, featuring expert perspectives and future possibilities.
Heat Index
Serious53/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Precision Neuroscience draws attention at the 18th percentile but verifies reality at the 52nd percentile among biometric robots. Hype Gap -33.4, 23rd widest among biometric robots.
6-month trend
Analysis
Clean safety record across 2 verified deployments. Deployment footprint remains limited relative to category peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Sep 23, 2026